Insider · CIK 0001177082

LYNCH DANIEL

Reports to the SEC for 11 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001177082

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-01	SpringWorks Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−93K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,447 sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−232K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,464 sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.3K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.8K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.2K sh	—	—	0
2025-05-14	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+10.1K sh	—	—	93,004
2025-02-20	SpringWorks Therapeutics, Inc.S Sale	Director	SSale	−44K sh	$60.14	−$2.65M	86,526
2025-02-20	SpringWorks Therapeutics, Inc.S Sale	Director	SSale	−3,582 sh	$61.24	−$219K	82,944
2025-02-14	SpringWorks Therapeutics, Inc.S Sale	Director	SSale	−400 sh	$60.00	−$24K	130,544
2025-02-10	SpringWorks Therapeutics, Inc.S Sale	Director	SSale	−69.8K sh	$53.23	−$3.71M	236,178
2025-02-10	SpringWorks Therapeutics, Inc.S Sale	Director	SSale	−39.6K sh	$54.88	−$2.18M	196,544
2025-02-10	SpringWorks Therapeutics, Inc.S Sale	Director	SSale	−65.6K sh	$55.51	−$3.64M	130,944
2024-05-16	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+4,095 sh	—	—	305,944
2024-05-16	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.2K sh	—	—	12,216
2023-06-13	2seventy bio, Inc.A Award	Director	AAward	+8,400 sh	—	—	21,053
2023-06-13	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+16.9K sh	—	—	16,900
2023-05-24	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+4,648 sh	—	—	301,849
2023-05-24	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+13.8K sh	—	—	13,774
2022-06-08	2seventy bio, Inc.A Award	Director	AAward	+7,200 sh	—	—	12,653
2022-06-08	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+14.4K sh	—	—	14,400
2022-05-19	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+4,818 sh	—	—	297,201
2022-05-19	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.3K sh	—	—	15,318
2021-11-11	2seventy bio, Inc.A Award	Director	AAward	+2,803 sh	—	—	5,453
2021-11-11	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+7,660 sh	—	—	7,660
2021-11-11	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+3,445 sh	—	—	3,445
2021-11-11	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+3,445 sh	—	—	3,445
2021-11-11	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+1,837 sh	—	—	1,837
2021-11-11	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+1,837 sh	—	—	1,837
2021-11-11	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+1,837 sh	—	—	1,837
2021-11-11	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+1,837 sh	—	—	1,837
2021-11-11	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+1,378 sh	—	—	1,378
2021-11-11	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+4,507 sh	—	—	4,507
2021-11-11	bluebird bio, Inc.J Other	Director	JOther	0 sh	—	—	7,959
2021-11-11	bluebird bio, Inc.Stock Option (right to buy)J Other	Director	JOther	−23.3K sh	—	—	22,981
2021-11-11	bluebird bio, Inc.Stock Option (right to buy)J Other	Director	JOther	−10.5K sh	—	—	10,337
2021-11-11	bluebird bio, Inc.Stock Option (right to buy)J Other	Director	JOther	−10.5K sh	—	—	10,337
2021-11-11	bluebird bio, Inc.Stock Option (right to buy)J Other	Director	JOther	−5,600 sh	—	—	5,513
2021-11-11	bluebird bio, Inc.Stock Option (right to buy)J Other	Director	JOther	−5,600 sh	—	—	5,513
2021-11-11	bluebird bio, Inc.Stock Option (right to buy)J Other	Director	JOther	−5,600 sh	—	—	5,513
2021-11-11	bluebird bio, Inc.Stock Option (right to buy)J Other	Director	JOther	−5,600 sh	—	—	5,513
2021-11-11	bluebird bio, Inc.Stock Option (right to buy)J Other	Director	JOther	−4,200 sh	—	—	4,135
2021-11-11	bluebird bio, Inc.Stock Option (right to buy)J Other	Director	JOther	−7,000 sh	—	—	0
2021-06-15	bluebird bio, Inc.A Award	Director	AAward	+4,353 sh	—	—	12,312
2021-06-15	bluebird bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2021-05-20	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+1,106 sh	—	—	292,383
2021-05-20	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+6,998 sh	—	—	6,998
2020-12-17	Translate Bio, Inc.G Gift	Director	GGift	−100K sh	—	—	221,825

Recent filings

Accepted (ET)
Jul 24
LYNCH DANIEL0001104659-25-065321
SEC(opens sec.gov)
May 154
LYNCH DANIEL0001104659-25-049662
SEC(opens sec.gov)
Feb 244
LYNCH DANIEL0001104659-25-016614
SEC(opens sec.gov)
Feb 194
LYNCH DANIEL0001104659-25-015215
SEC(opens sec.gov)
Feb 124
LYNCH DANIEL0001104659-25-012364
SEC(opens sec.gov)
May 174
LYNCH DANIEL0001104659-24-062992
SEC(opens sec.gov)
Jun 154
LYNCH DANIEL0001562180-23-005219
SEC(opens sec.gov)
May 254
LYNCH DANIEL0001104659-23-064648
SEC(opens sec.gov)

Companies

Address

C/O BIND THERAPEUTICS, INC. 325 VASSAR STREET

CAMBRIDGE, MA, 02139